Rifabutin-induced cystoid macular oedema
Related Experiment Video
Updated: Oct 2, 2026
11:20
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
1Jules Gonin Eye Hospital, University Department of Ophthalmology, Avenue de France 15, 1004 Lausanne, Switzerland.
The Journal of Antimicrobial Chemotherapy
|January 30, 2002
Abstract:
Rifabutin is a semi-synthetic antimycobacterial agent mainly used in the treatment of Mycobacterium avium-complex (MAC) in AIDS patients. Rifabutin-induced anterior uveitis has been reported previously. We report the case of a rifabutin-induced cystoid macular oedema (CMO) in an immunocompetent patient with pulmonary MAC infection. As far as we know, CMO secondary to rifabutin therapy has not been described previously.